Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Comptes Rendus Biologies|July 5, 2022
Liver cell circuits and therapeutic discovery for advanced liver disease and cancerEmilie Crouchet, Catherine Schuster, Thomas F BaumertCells|April 9, 2020
Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesNatascha Roehlen, Emilie Crouchet, Thomas F BaumertExpert Review of Proteomics|June 20, 2017
Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impactEmilie Crouchet, Thomas F Baumert, Catherine SchusterViruses|November 6, 2015
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionMirjam B Zeisel, Emilie Crouchet, Thomas F Baumert, et al.Therapeutic Advances in Gastroenterology|April 6, 2018
Host-targeting therapies for hepatitis C virus infection: current developments and future applicationsEmilie Crouchet, Florian Wrensch, Catherine Schuster, et al.Gut|September 10, 2016
Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol effluxEmilie Crouchet, Mathieu Lefèvre, Eloi R Verrier, et al.Nutrients|March 13, 2024
Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse ModelAnouk Charlot, Anthony Bringolf, Léa Debrut, et al.Frontiers in Immunology|July 7, 2018
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine DesignFlorian Wrensch, Emilie Crouchet, Gaetan Ligat, et al.American Journal of Physiology. Cell Physiology|June 16, 2026
High-fat, low-carb diet reduces tumor growth and induces liver metabolism remodeling in a breast cancer mouse modelAnouk Charlot, Anthony Bringolf, Joris Mallard, et al.Oncogene|July 7, 2026
Humanized anti-Claudin-1 antibodies to treat colorectal cancerMark Primeaux, Zeina Nehme, Iram Fatima, et al.Pageof 4